Multiple Choice
Scientists measured whether individuals who had been vaccinated with anti-HPV vaccines (Gardasil and Cervarix) had detectable levels of anti-HPV antibodies in their blood many years after receiving the vaccines. The data are shown here. Based only on these data, which of the following policy recommendations would you make to the United States Center for Disease Control and Prevention (the agency that sets vaccination schedules) regarding anti-HPV vaccines? 
A) Individuals who are vaccinated with Cervarix will never need a "booster" shot even 30 years after initially being vaccinated.
B) Gardasil protects against HPV-related cancer better than Cervarix, so individuals should be vaccinated with Gardasil and not Cervarix.
C) After many years, Cervarix is about twice as effective at preventing HPV-related cancer than Gardasil, so individuals should be vaccinated with Cervarix and not Gardasil.
D) If people are vaccinated with Gardasil, they may need a "booster" shot in the future to maintain high levels of protection from HPV-related cancers.
Correct Answer:

Verified
Correct Answer:
Verified
Q53: Suppose that a person has a mutation
Q54: What type of immune response is always
Q55: The human lymphatic system consists of all
Q56: Which of the following cell types is
Q57: Where is the antigen-binding site of this
Q59: The second vaccination is beneficial because it<br>A)
Q60: Suppose you design a study to test
Q61: The basic function of activated T cells
Q62: Suppose you design a study to test
Q63: Which of the following cell types is